The disturbance of circadian rhythms and desynchronosis encountered by jet travelers, shift workers, persons on unconventional sleep- wake schedules and in aerospace operations, affect human physical performances as well as health. A number of treatments have been tested or suggested to alleviate the deleterious symptoma-tology associated with internal rhythm disturbances. However, many of the drugs which have been tested or utilized as experimental chronobiotics are inappropriate for operational use due to their high toxicity, negative side effects or long lasting action. The objective of the current proposal is to elucidate the neurochemical mechanisms of the beneficial effect of drugs which have been reported to be useful in facilitating readaptation following phase shifts in an attempt to find the most effective and safe way to facilitate readaptation to phase shifts. To achieve this goal, the effects of chronobiotic drugs on the circadian rhythm of levels of acetylcholine, norepinephrine, dopamine, serotonin and neuropeptides will be studied in specific rat brain regions. Caffeine, theophylline, imipramine and ethanol will be used as representative chronobiotic drugs in these studies. The effects of these drugs on the various variables will be evaluated in rats kept under different light regimens. The rat is used as the experimental animal because it is a well established model in chronobiological research and the rat simulates man in its directional assymetry in response to phase shift. A better understanding of the role of neurotransmitters and neuromodulators in phase shifts and phase shift readaptation will contribute in finding the most effective and safest way to facilitate readaptation following desynchronosis.

Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Florida Agricultural and Mechanical University
Department
Type
DUNS #
City
Tallahassee
State
FL
Country
United States
Zip Code
32307
Johnston, Jermaine G; Pollock, David M (2018) Circadian regulation of renal function. Free Radic Biol Med 119:93-107
Adams, Mark K; Lee, Seung-Ah; Belyaeva, Olga V et al. (2017) Characterization of human short chain dehydrogenase/reductase SDR16C family members related to retinol dehydrogenase 10. Chem Biol Interact 276:88-94
Mochona, Bereket; Jackson, Timothy; McCauley, DeCoria et al. (2016) Synthesis and Cytotoxic Evaluation of Pyrrole Hetarylazoles Containing Benzimidazole/Pyrazolone/1,3,4-Oxadiazole Motifs. J Heterocycl Chem 53:1871-1877
Engel, Krysta L; French, Sarah L; Viktorovskaya, Olga V et al. (2015) Spt6 Is Essential for rRNA Synthesis by RNA Polymerase I. Mol Cell Biol 35:2321-31
Ayuk-Takem, Lambert; Amissah, Felix; Aguilar, Byron J et al. (2014) Inhibition of polyisoprenylated methylated protein methyl esterase by synthetic musks induces cell degeneration. Environ Toxicol 29:466-77
Chougule, Mahavir B; Patel, Apurva R; Patlolla, Ram et al. (2014) Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption. J Drug Target 22:498-508
Culpepper, Bonnie K; Webb, William M; Bonvallet, Paul P et al. (2014) Tunable delivery of bioactive peptides from hydroxyapatite biomaterials and allograft bone using variable-length polyglutamate domains. J Biomed Mater Res A 102:1008-16
Errahali, Younes J; Thomas, Leeshawn D; Keller 3rd, Thomas C S et al. (2013) Inhibition by new glucocorticoid antedrugs [16?, 17?-d] isoxazoline and [16?, 17?-d]-3'-hydroxy-iminoformyl isoxazoline derivatives of chemotaxis and CCL26, CCL11, IL-8, and RANTES secretion. J Interferon Cytokine Res 33:493-507
Stephenson, Adrienne P; Schneider, Jeffrey A; Nelson, Bryant C et al. (2013) Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and N-acetylcysteine. Toxicol Lett 218:299-307
Godugu, Chandraiah; Patel, Apurva R; Doddapaneni, Ravi et al. (2013) Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models. J Control Release 172:86-95

Showing the most recent 10 out of 40 publications